Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 2, Pages 255
Publisher
MDPI AG
Online
2018-01-24
DOI
10.3390/ijms19020255
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug Delivery Nanoparticles in Treating Chemoresistant Tumor Cells
- (2018) Giuseppina Barrera et al. CURRENT MEDICINAL CHEMISTRY
- Recent advances in malignant melanoma
- (2017) Victoria Atkinson INTERNAL MEDICINE JOURNAL
- Solid Lipid Nanoparticles Loaded with Antitumor Lipophilic Prodrugs Aimed to Glioblastoma Treatment: Preliminary Studies on Cultured Cells
- (2017) Laura Annovazzi et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433)
- (2017) Sonali Kumari et al. Scientific Reports
- Solid lipid nanoparticles carrying lipophilic derivatives of doxorubicin: preparation, characterization, andin vitrocytotoxicity studies
- (2016) Elena Peira et al. JOURNAL OF MICROENCAPSULATION
- Temozolomide-loaded PLGA nanoparticles to treat glioblastoma cells: a biophysical and cell culture evaluation
- (2016) Jeyarama S. Ananta et al. NEUROLOGICAL RESEARCH
- Formulation of temozolomide-loaded nanoparticles and their targeting potential to melanoma cells
- (2016) Guan Jiang et al. ONCOLOGY REPORTS
- Thrombin Cleavage of Osteopontin Modulates Its Activities in Human CellsIn Vitroand Mouse Experimental Autoimmune EncephalomyelitisIn Vivo
- (2016) Elena Boggio et al. Journal of Immunology Research
- Temozolomide Nanoparticles for Targeted Glioblastoma Therapy
- (2015) Chen Fang et al. ACS Applied Materials & Interfaces
- Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma
- (2015) Sang-Soo Kim et al. CANCER LETTERS
- Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo
- (2014) Guan Jiang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Metastatic melanoma cell lines do not secrete IL-1β but promote IL-1β production from macrophages
- (2014) Samuel Gehrke et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Solid Lipid Nanoparticles Loaded with Fluorescent-labelled Cyclosporine A: Anti-Inflammatory Activity In Vitro
- (2014) Marina Gallarate et al. PROTEIN AND PEPTIDE LETTERS
- Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery
- (2012) Luigi Battaglia et al. Expert Opinion on Drug Delivery
- Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)
- (2011) Poulam M. Patel et al. EUROPEAN JOURNAL OF CANCER
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Combination of BH3-Mimetic ABT-737 with the Alkylating Agent Temozolomide Induces Strong Synergistic Killing of Melanoma Cells Independent of p53
- (2011) Steven N. Reuland et al. PLoS One
- Solid lipid nanoparticles produced through a coacervation method
- (2010) Luigi Battaglia et al. JOURNAL OF MICROENCAPSULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now